By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



5102 20th Street East
Building 100
Tacoma  Washington  98424  U.S.A.
Phone: 253-922-2600 Fax: n/a


Company News
Revalesio Expands FANTOM II Clinical Trial To Europe 4/23/2015 2:18:14 PM
Revalesio's RNS60 Demonstrates Promise In Treating Alzheimer's Disease And Other Dementias 10/20/2014 9:36:40 AM
Revalesio Names Bert van den Bergh President 10/20/2014 9:35:18 AM
Revalesio Presents Update On The Development Of RNS60 As A Therapeutic For Acute Heart Disease At The American Heart Association Scientific Sessions 11/18/2013 7:36:27 AM
Revalesio Initiates Phase IIa Study of RNS60 in Multiple Sclerosis at University Hospital Zurich 11/11/2013 10:44:44 AM
Mouse Model of Parkinson's Disease Shows Improved Brain Function, Motor Skills Due to Revalesio's RNS60 10/17/2013 9:09:34 AM
Revalesio Presents Data Showing RNS60 Alters Disease Progression in Animal Model of Alzheimer's Disease Through the PI3k-Akt Pathway 7/18/2013 9:23:49 AM
Revalesio's RNS60 Protects Myelin and Halts Multiple Sclerosis in Mice 1/3/2013 9:54:42 AM
Revalesio's RNS60 Demonstrates Promise in First Human Asthma Trial 10/31/2011 11:53:07 AM
Revalesio to Present Research on the Anti-Inflammatory Effects of RNS60 in Asthma 3/17/2011 9:09:41 AM